摘要
目的探讨内脏脂肪素(Visfatin)、脂联素(APN)、瘦素水平与肥胖及2型糖尿病(T2DM)的关系。方法 85例研究对象分为糖耐量正常(NGT)组和T2DM组。根据BMI,NGT组再分为正常对照(NC)组和单纯肥胖(S-Ob)组,T2DM组再分为糖尿病非肥胖(T2DM NOb)组和糖尿病肥胖(T2DMOb)组,测定并分析各组Visfatin、APN、瘦素水平并对影响因素进行相关分析。结果 (1)四组间Visfatin、APN、瘦素、FIns、HDL-C差异均有统计学意义(P<0.05或P<0.01)。(2)85例研究对象分为肥胖组及正常体重对照组,两组间Visfatin、瘦素、FIns、HDL-C、尿酸差异有统计学意义(P<0.05或P<0.01)。(3)WHR是Visfatin的独立影响因素(r=0.519,P<0.05)。结论 Visfatin可能在肥胖和T2DM的发生和发展中有一定作用。
Objective To study the relationship of visfatin, adiponectin and leptin levels with obesity and diabetes. Methods 85 cases of subjects included normal glucose tolerance (NGT) group (n =20), type 2 diabetes mellitus (T2DM) group (n=43) and simple obesity group (S-Ob,n=22). T2DM had subgroups of T2DM-Ob (n = 22) and T2DM without Ob (n = 21). Visfatin, adiponectin and leptin were determined. Results (1) Among the four groups, the differences in visfatin, adiponectin, leptin, fasting insulin and high-density lipoprotein cholesterol (HDL-C) were statistically significant(P〈0. 05, or P〈0.01). (2) The differences in visfatin, leptin, fasting insulin, HDL-C,cholesterol and uric acid(P〈0.05, or P〈0. 01)were significant between obesity and non-obesity. (3) Waist-to-hip ratio was an independent influencing factors for visfatin. (r=0. 519, P〈0. 05). Conclusion Visfatin may play a role in the occurrence and development of obesity and DM.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2010年第12期883-885,共3页
Chinese Journal of Diabetes
基金
浙江省丽水市科学技术局资助项目(2008-69)
关键词
内脏脂肪素
脂联素
瘦素
糖尿病
2型
胰岛素抵抗
肥胖
Visfatin
Adiponectin
Leptin
Diabetes mellitus, type 2
Insulin resistance
Obesity